• Home
  • R&D

R&D

OliX Pipeline

  • Pipeline
  • OLX101A
  • OLX104C
  • OLX301A
  • OLX301D
  • OLX702A
  • OLX703A

To overcome limitations in stability and delivery and minimize siRNA’s toxicity, OliX concentrates on the development
of RNAi therapeutics for dermal, ophthalmic, pulmonary and liver diseases.